NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free AVNS Stock Alerts $19.68 -0.03 (-0.15%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$19.34▼$19.9450-Day Range$17.85▼$19.9452-Week Range$17.24▼$26.56Volume246,254 shsAverage Volume211,695 shsMarket Capitalization$909.22 millionP/E RatioN/ADividend YieldN/APrice Target$31.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Avanos Medical alerts: Email Address Avanos Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside57.5% Upside$31.00 Price TargetShort InterestHealthy2.59% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 13 Articles This WeekInsider TradingSelling Shares$152,960 Sold Last QuarterProj. Earnings Growth31.88%From $1.38 to $1.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.71 out of 5 starsMedical Sector228th out of 904 stocksSurgical Appliances & Supplies Industry8th out of 18 stocks 3.3 Analyst's Opinion Consensus RatingAvanos Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAvanos Medical has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.59% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Avanos Medical has recently decreased by 0.85%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 2.3 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Avanos Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AVNS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have sold 1,441.16% more of their company's stock than they have bought. Specifically, they have bought $9,925.00 in company stock and sold $152,960.00 in company stock.Percentage Held by InsidersOnly 2.90% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 31.88% in the coming year, from $1.38 to $1.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Avanos Medical Stock (NYSE:AVNS)Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesMay 3, 2024 | finance.yahoo.comAvanos Medical First Quarter 2024 Earnings: EPS: US$0.011 (vs US$0.17 loss in 1Q 2023)May 3, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 5, 2024 | Weiss Ratings (Ad)55x Gains Instead of 9x GainsWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”May 2, 2024 | msn.comAVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue EstimatesMay 2, 2024 | sfgate.comAvanos Medical: Q1 Earnings SnapshotMay 2, 2024 | prnewswire.comAvanos Medical, Inc. Announces First Quarter 2024 ResultsMay 1, 2024 | msn.comAvanos Medical Q1 2024 Earnings PreviewMay 5, 2024 | Weiss Ratings (Ad)55x Gains Instead of 9x GainsWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”April 25, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial ResultsApril 19, 2024 | finance.yahoo.comHere's Why Shareholders May Want To Be Cautious With Increasing Avanos Medical, Inc.'s (NYSE:AVNS) CEO Pay PacketFebruary 22, 2024 | finance.yahoo.comAvanos Medical Full Year 2023 Earnings: US$0.21 loss per share (vs US$1.08 profit in FY 2022)February 22, 2024 | markets.businessinsider.comAvanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | prnewswire.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | msn.comSupplementary Review: Avanos Medical (AVNS), February 20, 2024February 20, 2024 | seekingalpha.comAvanos Medical, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 20, 2024 | msn.comAvanos Medical reports mixed Q4 results; initiates FY24 outlookFebruary 20, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 20, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Reports Mixed 2023 Financial Results Amid Transformation InitiativeFebruary 20, 2024 | prnewswire.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 17, 2024 | finance.yahoo.comAVNS Mar 2024 20.000 callFebruary 16, 2024 | msn.comAvanos Medical Q4 2023 Earnings PreviewFebruary 15, 2024 | finance.yahoo.comAvanos Medical, Inc. (AVNS)February 14, 2024 | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Avanos Medical (AVNS), Incyte (INCY)February 14, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial ResultsSee More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today5/05/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees3,771Year FoundedN/APrice Target and Rating Average Stock Price Target$31.00 High Stock Price Target$31.00 Low Stock Price Target$31.00 Potential Upside/Downside+57.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E Ratio14.26 P/E GrowthN/ANet Income$-61,800,000.00 Net Margins-9.15% Pretax Margin-0.88% Return on Equity3.98% Return on Assets2.91% Debt Debt-to-Equity Ratio0.14 Current Ratio2.28 Quick Ratio1.38 Sales & Book Value Annual Sales$673.30 million Price / Sales1.35 Cash Flow$2.02 per share Price / Cash Flow9.73 Book Value$26.58 per share Price / Book0.74Miscellaneous Outstanding Shares46,200,000Free Float44,863,000Market Cap$909.22 million OptionableOptionable Beta0.97 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 58)CEO & Director Comp: $2.21MMr. Michael C. Greiner (Age 51)Senior VP, CFO & Chief Transformation Officer Comp: $986.42kMs. Mojirade James (Age 57)Senior VP, General Counsel & Corporate Secretary Comp: $728.66kMr. Kerr W. Holbrook (Age 57)Senior VP & Chief Commercial Officer Comp: $747.61kMr. Sudhakar Varshney (Age 47)Senior Vice President of Global Supply Chain & Procurement Comp: $1.02MMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSenior VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVice President of Strategy & Corporate DevelopmentJohn W. CatoVice President of Human ResourcesMore ExecutivesKey CompetitorsJin Medical InternationalNASDAQ:ZJYLEstablishment LabsNASDAQ:ESTASanara MedTechNASDAQ:SMTIEnovisNYSE:ENOVViridian TherapeuticsNASDAQ:VRDNView All CompetitorsInsiders & InstitutionsBNP Paribas Financial MarketsBought 40,653 shares on 5/1/2024Ownership: 0.116%Janney Montgomery Scott LLCBought 2,082 shares on 5/1/2024Ownership: 0.028%Principal Financial Group Inc.Bought 3,550 shares on 4/29/2024Ownership: 0.556%Yousif Capital Management LLCSold 2,260 shares on 4/26/2024Ownership: 0.046%UMB Bank n.a.Sold 581 shares on 4/26/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions AVNS Stock Analysis - Frequently Asked Questions Should I buy or sell Avanos Medical stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AVNS shares. View AVNS analyst ratings or view top-rated stocks. What is Avanos Medical's stock price target for 2024? 2 Wall Street analysts have issued 1-year price targets for Avanos Medical's shares. Their AVNS share price targets range from $31.00 to $31.00. On average, they predict the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 57.5% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts. How have AVNS shares performed in 2024? Avanos Medical's stock was trading at $22.43 on January 1st, 2024. Since then, AVNS shares have decreased by 12.3% and is now trading at $19.68. View the best growth stocks for 2024 here. Are investors shorting Avanos Medical? Avanos Medical saw a decrease in short interest in March. As of March 31st, there was short interest totaling 1,180,000 shares, a decrease of 11.9% from the March 15th total of 1,340,000 shares. Based on an average daily volume of 291,100 shares, the days-to-cover ratio is presently 4.1 days. Approximately 2.6% of the shares of the stock are short sold. View Avanos Medical's Short Interest. When is Avanos Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our AVNS earnings forecast. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings data on Tuesday, February, 20th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.01. The firm earned $173.30 million during the quarter, compared to analyst estimates of $170.43 million. Avanos Medical had a positive trailing twelve-month return on equity of 3.98% and a negative net margin of 9.15%. The firm's revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.60 earnings per share. What ETF holds Avanos Medical's stock? Invesco S&P SmallCap Health Care ETF holds 84,593 shares of AVNS stock, representing 0.75% of its portfolio. What guidance has Avanos Medical issued on next quarter's earnings? Avanos Medical updated its FY 2024 earnings guidance on Friday, May, 3rd. The company provided earnings per share (EPS) guidance of 1.300-1.450 for the period, compared to the consensus earnings per share estimate of 1.380. The company issued revenue guidance of $685.0 million-$705.0 million, compared to the consensus revenue estimate of $691.0 million. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA). Who are Avanos Medical's major shareholders? Avanos Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (1.61%), Principal Financial Group Inc. (0.56%), New York State Teachers Retirement System (0.16%), BNP Paribas Financial Markets (0.12%), Yousif Capital Management LLC (0.05%) and Maryland State Retirement & Pension System (0.04%). Insiders that own company stock include Julie Ann Shimer, Michael Greiner and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AVNS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldCharles Payne Demystifies OptionsUnstoppable ProsperityThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.